INSP Logo

Inspire Medical Systems, Inc. (INSP) 

NYSE
Market Cap
$5.58B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
575 of 774
Rank in Industry
70 of 99

Largest Insider Buys in Sector

INSP Stock Price History Chart

INSP Stock Performance

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The …

Insider Activity of Inspire Medical Systems, Inc.

Over the last 12 months, insiders at Inspire Medical Systems, Inc. have bought $0 and sold $24.15M worth of Inspire Medical Systems, Inc. stock.

On average, over the past 5 years, insiders at Inspire Medical Systems, Inc. have bought $15,350 and sold $146.77M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 100 shares for transaction amount of $15,350 was made by Sparks Charisse Y (Chief Medical Officer) on 2023‑10‑12.

List of Insider Buy and Sell Transactions, Inspire Medical Systems, Inc.

2024-11-01SaleChief Technology Officer
8,703
0.0296%
$193.47$1.68M+1.05%
2024-09-09Saledirector
800
0.0028%
$220.00$176,000-3.56%
2024-09-09SaleChief Technology Officer
31
0.0001%
$215.00$6,665-3.56%
2024-08-22SaleChief Technology Officer
5,000
0.0171%
$189.83$949,143+8.35%
2024-08-16SaleChief Commercial Officer
4,861
0.0158%
$188.55$916,5490.00%
2024-08-15SaleChief Commercial Officer
16,139
0.0538%
$193.10$3.12M0.00%
2024-04-17SaleChief Financial Officer
15,000
0.0468%
$230.03$3.45M-22.53%
2024-04-01SaleCEO and President
40,000
0.1323%
$205.09$8.2M-7.63%
2024-04-01Saledirector
32
0.0001%
$213.99$6,848-7.63%
2024-03-25Saledirector
554
0.0018%
$197.81$109,587-4.87%
2024-03-22SaleChief Technology Officer
4,387
0.0146%
$194.40$852,849-1.06%
2024-03-18Saledirector
554
0.0018%
$193.53$107,216-1.50%
2024-03-11Saledirector
554
0.0019%
$198.05$109,720-0.81%
2024-03-01Saledirector
554
0.0018%
$179.44$99,410+6.39%
2024-02-29SaleChief Technology Officer
8,605
0.0289%
$179.25$1.54M+9.04%
2024-02-27SaleChief Commercial Officer
3,060
0.0102%
$182.01$556,951+5.46%
2024-02-23SaleChief Commercial Officer
12,230
0.0415%
$185.37$2.27M+4.94%
2023-10-12PurchaseChief Medical Officer
100
0.0004%
$153.50$15,350+26.57%
2023-09-08SaleCEO and President
47,992
$0$0-17.40%
2023-07-31Saledirector
529
0.0018%
$290.47$153,659-34.31%

Insider Historical Profitability

89.73%
Herbert Timothy P.CEO and President
63658
0.2124%
$186.11130+89.73%
Buchholz RichardChief Financial Officer
28271
0.0943%
$186.11119+89.73%
McCormick Shawndirector
23140
0.0772%
$186.1111+89.73%
Ban RandyChief Commercial Officer
3056
0.0102%
$186.11134+89.73%
Amzak Health Investors, LLC10 percent owner
1497043
4.9957%
$186.1110+89.73%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fidelity Investments$953.19M14.944.44M+36.23%+$253.5M0.06
The Vanguard Group$621.26M9.742.89M-1.33%-$8.39M0.01
Wellington Management Company$419.41M6.571.95M+36.52%+$112.2M0.07
BlackRock$406.17M6.371.89M+5.04%+$19.51M0.01
Baillie Gifford Co$315.23M4.941.47M+19.33%+$51.06M0.25
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.